| NO |
Publication |
| 1 |
First-Line Afatinib 30 mg 40 mg in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutations: Real-world Efficacy and Tolerability in Taiwan. 洪會洋, 李岱晃, 莊政皓, 李玫萱, 吳寬澧, 郭家佑, 黃虹綾, 黃鍾文, 蔡毓真, 洪仁宇, 鍾飲文, 楊志仁* - - 1 - ANTICANCER RESEARCH - ANTICANCER RESEARCH 2026 46卷(2期):917-938頁 (IF: 1.8, 領域排名: 264, 領域期刊數: 333, 領域排名: 79.28%) First-Line Afatinib 30 mg 40 mg in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutations: Real-world Efficacy and Tolerability in Taiwan. Hui-Yang Hung, Tai-Huang Lee, Cheng-Hao Chuang, Mei-Hsuan Lee, Kuan-Li Wu, Chia-Yu Kuo, Hung-Ling Huang, Chung-Wen Huang, Yu-Chen Tsai, Jen-Yu Hung, Inn-Wen Chong, Chih-Jen Yang* - - 1 - ANTICANCER RESEARCH - ANTICANCER RESEARCH 2026;46(2):917-938 (IF: 1.8, Journal Ranking: 264, Number of Journals of this Field: 333, Ranking: 79.28%) |
| 2 |
Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR-Mutated Advanced Nonsmall-Cell Lung Cancer. 郭家佑,黃天祈, 楊志仁,李玫萱, 李瑞英, 蔡英明, 吳寬澧, 莊政皓,鍾飲文, 洪仁宇* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2026 42卷(3期):e70105頁 (IF: 3.1, 領域排名: 92, 領域期刊數: 191, 領域排名: 48.17%) Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR-Mutated Advanced Nonsmall-Cell Lung Cancer. Chia-Yu Kuo, Tien-Chi Huang, Chih-Jen Yang, Mei-Hsuan Lee, Jui-Ying Lee, Ying-Ming Tsai, Kuan-Li Wu, Cheng-Hao Chuang, Inn-Wen Chong, Jen-Yu Hung - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2026;42(3):e70105 (IF: 3.1, Journal Ranking: 92, Number of Journals of this Field: 191, Ranking: 48.17%) |
| 3 |
Downregulated antisense lncRNA contributes to the development of lung adenocarcinoma. 姜宏興, 翁采彤, 張昭元,吳寬澧,吳宇瑗, 賴佳辰, 沈子彥,洪仁宇,李孝貞,蔡英明*, 許雅玲 - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14卷(2期):854-868頁 (IF: 3.6, 領域排名: 106, 領域期刊數: 322, 領域排名: 32.92%) Downregulated antisense lncRNA contributes to the development of lung adenocarcinoma. Hung-Hsing Chiang, Chai-Tung Ong, Chao-Yuan Chang, Kuan-Li Wu, Yu-Yuan Wu, Jia-Chen Lai, Tzu-Yen Shen, Jen-Yu Hung, Hsiao-Chen Lee, Ying-Ming Tsai, Ya-Ling Hsu - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(2):854-868 (IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%) |
| 4 |
Upregulated enhancer of rudimentary homolog promotes epithelial‑mesenchymal transition and cancer cell migration in lung adenocarcinoma. 蔡英明, 吳寬澧,黃永麒 Yu-Yuan Wu, Chao-Yuan Chang, 張永裕, 姜宏興, 劉伶秀, 洪仁宇* - - 1 - MOLECULAR MEDICINE REPORTS - MOLECULAR MEDICINE REPORTS 2024 29卷(1期):9頁 (IF: 3.4, 領域排名: 76, 領域期刊數: 189, 領域排名: 40.21%) Upregulated enhancer of rudimentary homolog promotes epithelial‑mesenchymal transition and cancer cell migration in lung adenocarcinoma. Ying-Ming Tsai, Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang, Hung-Hsing Chiang, Lian-Xiu Liu, Jen-Yu Hung* - - 1 - MOLECULAR MEDICINE REPORTS - MOLECULAR MEDICINE REPORTS 2024;29(1):9 (IF: 3.4, Journal Ranking: 76, Number of Journals of this Field: 189, Ranking: 40.21%) |
| 5 |
Intestinal capillariasis: An indigenous case in Taiwan. 李威德,Chih-Lin Huang, 林榮峙, 陳昭儒, 吳寬澧, 李俊德, 蘇月秋* - - 1 - JOURNAL OF MICROBIOLOGY, IMMUNOLOGY, AND INFECTION - JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 2024 57卷(2024期):520-522頁 (IF: 4.5, 領域排名: 40, 領域期刊數: 161, 領域排名: 24.84%) Intestinal capillariasis: An indigenous case in Taiwan. Wei-Te Lee, Chih-Lin Huang, Rong-Jyh Lin, Chao-Ju Chen, Kuan-Li Wu, June-Der Lee, Yue-Chiu Su - - 1 - JOURNAL OF MICROBIOLOGY, IMMUNOLOGY, AND INFECTION - JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION 2024;57(2024):520-522 (IF: 4.5, Journal Ranking: 40, Number of Journals of this Field: 161, Ranking: 24.84%) |
| 6 |
PROM2上調在肺鱗狀細胞癌中促進癌細胞移行並導致不良預後 吳寬澧, 張昭元, 蔡英明, 賴佳辰, 洪仁宇, 林依宣, 蔡佩薰, 許雅玲* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14卷(4期):1561-1576頁 (IF: 3.6, 領域排名: 106, 領域期刊數: 322, 領域排名: 32.92%) PROM2 upregulation promotes cancer cell migration and confers a poor prognosis in lung squamous cell carcinoma. Kuan-Li Wu, Chao-Yuan Chang, Ying-Ming Tsai, Jia-Chen Lai, Jen-Yu Hung, Yi-Shiuan Lin, Pei-Hsun Tsai, Ya-Ling Hsu* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(4):1561-1576 (IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%) |
| 7 |
Reconstruction of the Hepatic Microenvironment and Pathological Changes Underlying Type II Diabetes through Single-Cell RNA Sequencing. 戴嘉言, 蔡英明, 張昭元, 蔡鴻培, 吳寬澧, 吳宇瑗, Ling-Yu Wu, 簡淑芳, 蔡珮熏, 翁采彤, Chien-Hui Sun, 許雅玲* - - 1 - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 2024 20卷(14期):5531-5547頁 (IF: 8.2, 領域排名: 31, 領域期刊數: 313, 領域排名: 9.90%) Reconstruction of the Hepatic Microenvironment and Pathological Changes Underlying Type II Diabetes through Single-Cell RNA Sequencing. Chia-Yen Dai, Ying-Ming Tsai, Chao-Yuan Chang, Hung-Pei Tsai, Kuan-Li Wu, Yu-Yuan Wu, Ling-Yu Wu, Shu-Fang Jian, Pei-Hsun Tsai, Chai-Tung Ong, Chien-Hui Sun, Ya-Ling Hsu* - - 1 - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 2024;20(14):5531-5547 (IF: 8.2, Journal Ranking: 31, Number of Journals of this Field: 313, Ranking: 9.90%) |
| 8 |
Comprehensive analysis of the oncogenic potential of eukaryotic initiation factor 3M via SAAL1 interaction in lung adenocarcinoma. 姜宏興, 吳寬澧, 蔡鴻培, 翁采彤, 張昭元, 吳宇瑗, 沈子晏, 洪仁宇, 李孝貞, 許雅玲, 蔡英明* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14卷(10期):4817-4829頁 (IF: 3.6, 領域排名: 106, 領域期刊數: 322, 領域排名: 32.92%) Comprehensive analysis of the oncogenic potential of eukaryotic initiation factor 3M via SAAL1 interaction in lung adenocarcinoma. Hung-Hsing Chiang, Kuan-Li Wu, Hung-Pei Tsai, Chai-Tung Ong, Chao-Yuan Chang, Yu-Yuan Wu, Tzu-Yen Shen, Jen-Yu Hung, Hsiao-Chen Lee, Ya-Ling Hsu, Ying-Ming Tsai* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(10):4817-4829 (IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%) |
| 9 |
Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung. 郭家佑, 蔡明儒, 洪仁宇, 李玫萱, 吳寬澧, 蔡毓真, 莊政皓, 黃鍾文, Chin-Ling Chen,楊志仁*, 鍾飲文 - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024 40卷(5期):467-476頁 (IF: 2.7, 領域排名: 95, 領域期刊數: 189, 領域排名: 50.26%) Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung. Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, Mei-Hsuan Lee, Kuan-Li Wu, Yu-Chen Tsai, Cheng-Hao Chuang, Chung-Wen Huang, Chin-Ling Chen, Chih-Jen Yang*, Inn-Wen Chong - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2024;40(5):467-476 (IF: 2.7, Journal Ranking: 95, Number of Journals of this Field: 189, Ranking: 50.26%) |
| 10 |
A rare case of tracheal squamous cell carcinoma presented with critical airway obstruction 何晨宇, 劉又瑋, 賴薇安, 陳家閔, 吳寬澧* - - A - Respirology Case Reports - RESPIROLOGY CASE REPORTS 2024 12卷(9期):e70024頁 (IF: 0.8, 領域排名: 88, 領域期刊數: 100, 領域排名: 88.00%) A rare case of tracheal squamous cell carcinoma presented with critical airway obstruction Chen-Yu Ho, Yu-Wei Liu, Wei-An Lai, Chia-Min Chen, Kuan-Li Wu - - A - Respirology Case Reports - RESPIROLOGY CASE REPORTS 2024;12(9):e70024 (IF: 0.8, Journal Ranking: 88, Number of Journals of this Field: 100, Ranking: 88.00%) |
| 11 |
LAD1透過促進肺腺癌增生和增加侵襲性縮短肺癌患者存活 張昭元, 黃永琪, 姜宏興, 吳宇瑗, 吳寬澧, 張永裕, 劉伶琇, 蔡英明*, 許雅玲 - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023 24卷(1期):431頁 (IF: 5.6, 領域排名: 66, 領域期刊數: 285, 領域排名: 23.16%) Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma Chao-Yuan Chang, Yung-Chi Huang, Hung-Hsing Chiang, Yu-Yuan Wu, Kuan-Li Wu, Yung-Yun Chang, Lian-Xiu Liu, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023;24(1):431 (IF: 5.6, Journal Ranking: 66, Number of Journals of this Field: 285, Ranking: 23.16%) |
| 12 |
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes. 郭家佑, 蔡明儒, 洪仁宇, 吳寬澧, 蔡英明, 蔡毓真, 莊政皓, 李岱晃, 陳煌麒, 楊志仁*, 鍾飲文* - - 1 - CANCERS - CANCERS 2023 15卷(1期):187頁 (IF: 5.2, 領域排名: 72, 領域期刊數: 241, 領域排名: 29.88%) Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes. Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yu-Chen Tsai, Cheng-Hao Chuang, Tai-Huang Lee, Huang-Chi Chen, Chih-Jen Yang, Inn-Wen Chong - - 1 - CANCERS - CANCERS 2023;15(1):187 (IF: 5.2, Journal Ranking: 72, Number of Journals of this Field: 241, Ranking: 29.88%) |
| 13 |
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with -Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib. 蔡明儒, 洪仁宇, 馬瑞陽, 蔡毓真, 吳寬澧, 李玫萱, 郭家佑, 莊政皓, 李岱晃, 李彥龍, 黃鈞民, 沈玫秋, 楊志仁*, 鍾飲文* - - 1 - CANCERS - CANCERS 2023 15卷(7期):2019頁 (IF: 5.2, 領域排名: 72, 領域期刊數: 241, 領域排名: 29.88%) Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with -Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib. Ming-Ju Tsai, Jen-Yu Hung, Juei-Yang Ma, Yu-Chen Tsai, Kuan-Li Wu, Mei-Hsuan Lee, Chia-Yu Kuo, Cheng-Hao Chuang, Tai-Huang Lee, Yen-Lung Lee, Chun-Ming Huang, Mei-Chiou Shen, Chih-Jen Yang, Inn-Wen Chong - - 1 - CANCERS - CANCERS 2023;15(7):2019 (IF: 5.2, Journal Ranking: 72, Number of Journals of this Field: 241, Ranking: 29.88%) |
| 14 |
LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis. 吳寬澧,蔡英明,黃永琪,吳宇瑗,張昭元,劉又瑋,許雅玲,洪仁宇* - - 1 - THORACIC CANCER - THORACIC CANCER 2023 14卷(4期):407-418頁 (IF: 2.9, 領域排名: 43, 領域期刊數: 66, 領域排名: 65.15%) LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis. Kuan-Li Wu, Ying-Ming Tsai, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yu-Wei Liu, Ya-Ling Hsu, Jen-Yu Hung - - 1 - THORACIC CANCER - THORACIC CANCER 2023;14(4):407-418 (IF: 2.9, Journal Ranking: 43, Number of Journals of this Field: 66, Ranking: 65.15%) |
| 15 |
利用單細胞定序技術特徵化肋膜微環境 吳宇瑗, 許雅玲*, 黃詠琪, 蘇秋月, 吳寬澧, 張昭元, 翁采彤, 賴佳辰, 沈子宴, 洪仁宇, 蔡英明* - - 1 - THERANOSTICS - THERANOSTICS 2023 13卷(13期):4412-4429頁 (IF: 12.4, 領域排名: 8, 領域期刊數: 136, 領域排名: 5.88%) Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer Wu YY, Hsu YL*, Huang YC, Su YC, Wu KL, Chang CY, Ong CT, Lai JC, Shen TY, Lee TH, Hung JY, Tsai YM* - - 1 - THERANOSTICS - THERANOSTICS 2023;13(13):4412-4429 (IF: 12.4, Journal Ranking: 8, Number of Journals of this Field: 136, Ranking: 5.88%) |
| 16 |
Cysteinyl Leukotriene Pathway and Cancer. 蔡明儒,張維安,莊政皓,吳寬澧,鄭至宏,許超群,許雅玲,洪仁宇* - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022 23卷(1期):120頁 (IF: 6.208, 領域排名: 69, 領域期刊數: 296, 領域排名: 23.31%) Cysteinyl Leukotriene Pathway and Cancer. Ming-Ju Tsai, Wei-An Chang, Cheng-Hao Chuang, Kuan-Li Wu, Chih-Hung Cheng, Chau-Chyun Sheu, Ya-Ling Hsu, Jen-Yu Hung - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022;23(1):120 (IF: 6.208, Journal Ranking: 69, Number of Journals of this Field: 296, Ranking: 23.31%) |
| 17 |
Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis 蔡毓真,陳筱伶#,李岱晃,張秀美,吳寬澧,莊政皓,張詠婕,杜裕康,洪仁宇,楊志仁*,鍾飲文* - - 2 - cancers - CANCERS 2022 14卷(1期):182頁 (IF: 6.575, 領域排名: 60, 領域期刊數: 245, 領域排名: 24.49%) Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis Yu-Chen Tsai , Hsiao-Ling Chen, Tai-Huang Lee , Hsiu-Mei Chang , Kuan-Li Wu , Cheng-Hao Chuang , Yong-Chieh Chang , Yu-Kang Tu , Jen-Yu Hung , Chih-Jen Yang , Inn-Wen Chong - - 2 - cancers - CANCERS 2022;14(1):182 (IF: 6.575, Journal Ranking: 60, Number of Journals of this Field: 245, Ranking: 24.49%) |
| 18 |
Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma. 李孝貞, 張昭元#, 黃永麒, 吳寬澧, 姜宏興, 張永裕, Lian-Xiu Liu, 洪仁宇, 許雅玲, Yu-Yuan Wu, 蔡英明* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022 11卷(5期):760頁 (IF: 5.168, 領域排名: 21, 領域期刊數: 94, 領域排名: 22.34%) Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma. Hsiao-Chen Lee, Chao-Yuan Chang, Yung-Chi Huang, 吳寬澧, Hung-Hsing Chiang, Yung-Yun Chang, Lian-Xiu Liu, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu, Ying-Ming Tsai* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022;11(5):760 (IF: 5.168, Journal Ranking: 21, Number of Journals of this Field: 94, Ranking: 22.34%) |
| 19 |
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis 李岱晃,陳筱伶#,張秀美,吳秋玫,吳寬澧,莊政皓,郭家佑,魏伯儒,陳金鈴,劉憓陵,洪仁宇,楊志仁*,鍾飲文* - - 1 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2022 11卷(12期):3366頁 (IF: 4.964, 領域排名: 54, 領域期刊數: 172, 領域排名: 31.40%) Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis Tai-Huang Lee, Hsiao-Ling Chen, Hsiu-Mei Chang, Chiou-Mei Wu, Kuan-Li Wu, Chia-Yu Kuo, Po-Ju Wei, Chin-Ling Chen, Hui-Lin Liu, Jen-Yu Hung, Chih-Jen Yang, Inn-Wen Chong - - 1 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2022;11(12):3366 (IF: 4.964, Journal Ranking: 54, Number of Journals of this Field: 172, Ranking: 31.40%) |
| 20 |
The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy. 李孝貞, 張昭元#, 吳寬澧, 姜宏興, 張永裕, Lian-Xiu Liu, 黃永麒, 洪仁宇, 許雅玲, Yu-Yuan Wu, 蔡英明* - - 1 - JOURNAL OF PERSONALIZED MEDICINE - JOURNAL OF PERSONALIZED MEDICINE 2022 12卷(6期):902頁 (IF: 3.508, 領域排名: 41, 領域期刊數: 109, 領域排名: 37.61%) The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy. Hsiao-Chen Lee, Chao-Yuan Chang, Kuan-Li Wu, Hung-Hsing Chiang, Yung-Yun Chang, Lian-Xiu Liu, Yung-Chi Huang, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu, Ying-Ming Tsai* - - 1 - JOURNAL OF PERSONALIZED MEDICINE - JOURNAL OF PERSONALIZED MEDICINE 2022;12(6):902 (IF: 3.508, Journal Ranking: 41, Number of Journals of this Field: 109, Ranking: 37.61%) |
| 21 |
Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming. 吳寬澧, 黃永麒, Yu-Yuan Wu, 張昭元, 張永裕, 姜宏興, Lian-Xiu Liu, 蔡英明, 洪仁宇* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022 11卷(7期):975頁 (IF: 5.168, 領域排名: 21, 領域期刊數: 94, 領域排名: 22.34%) Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming. Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang, Hung-Hsing Chiang, Lian-Xiu Liu, Ying-Ming Tsai, Jen-Yu Hung - - 1 - BIOLOGY - BIOLOGY-BASEL 2022;11(7):975 (IF: 5.168, Journal Ranking: 21, Number of Journals of this Field: 94, Ranking: 22.34%) |
| 22 |
Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients. 許恩齊, 吳寬澧, 蔡英明, 李玫萱, 蔡明儒, 郭家佑, Yu-Chuan Liu, Fu-Wen Liang, 楊志仁, 洪仁宇* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38卷(10期):1001-1011頁 (IF: 2.996, 領域排名: 97, 領域期刊數: 139, 領域排名: 69.78%) Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients. En-Chi Hsu, Kuan-Li Wu, Ying-Ming Tsai, Mei-Hsuan Lee, Ming-Ju Tsai, Chia-Yu Kuo, Yu-Chuan Liu, Fu-Wen Liang, Chih-Jen Yang, Jen-Yu Hung* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(10):1001-1011 (IF: 2.996, Journal Ranking: 97, Number of Journals of this Field: 139, Ranking: 69.78%) |
| 23 |
Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma. 張昭元, Yung-Chi Huang, 姜宏興, Yu-Yuan Wu, 吳寬澧, 張永裕, 劉怜秀, 蔡英明*, 許雅玲 - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022 24卷(1期):431頁 (IF: 6.208, 領域排名: 69, 領域期刊數: 296, 領域排名: 23.31%) Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma. Chao-Yuan Chang, Yung-Chi Huang, Hung-Hsing Chiang, Yu-Yuan Wu, Kuan-Li Wu, Yung-Yun Chang, Lian-Xiu Liu, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022;24(1):431 (IF: 6.208, Journal Ranking: 69, Number of Journals of this Field: 296, Ranking: 23.31%) |
| 24 |
Single-Cell Transcriptomic Profiles of Lung Pre-Metastatic Niche Reveal Neutrophil and Lymphatic Endothelial Cell Roles in Breast Cancer. 黃詠琪, 張昭元,吳宇瑗, 吳寬澧, 李孝真,蔡英美, 許雅玲* - - 1 - Cancers - 2022 15卷(1期):176頁 (IF: 0, 領域排名: 0, 領域期刊數: 0, 領域排名: -%) Single-Cell Transcriptomic Profiles of Lung Pre-Metastatic Niche Reveal Neutrophil and Lymphatic Endothelial Cell Roles in Breast Cancer. Huang YC, Chang CY, Wu YY, Wu KL, Tsai YM, Lee HC, Tsai EM, Hsu YL. - - 1 - Cancers - 2022;15(1):176 (IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%) |
| 25 |
Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer 莊政皓,陳筱伶#,張秀美,蔡毓真,吳寬澧,陳宜樺,陳功超,李瑞英,張詠婕,陳金鈴,杜裕康,洪仁宇,楊志仁*,鍾飲文* - - 1 - cancers - CANCERS 2021 13卷(8期):1966頁 (IF: 6.639, 領域排名: 51, 領域期刊數: 242, 領域排名: 21.07%) Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer Cheng-Hao Chuang, Hsiao-Ling Chen, Hsiu-Mei Chang, Yu-Chen Tsai , Kuan-Li Wu , I-Hua Chen , Kung-Chao Chen, Jui-Ying Lee , Yong-Chieh Chang , Chin-Ling Chen , Yu-Kang Tu , Jen-Yu Hung , Chih-Jen Yang , Inn-Wen Chong - - 1 - cancers - CANCERS 2021;13(8):1966 (IF: 6.639, Journal Ranking: 51, Number of Journals of this Field: 242, Ranking: 21.07%) |
| 26 |
Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review. 許朝欽,許瑞峰,吳寬澧* - - 0 - Respirology case reports - 2021 9卷(6期):e00753頁 (IF: 0, 領域排名: 0, 領域期刊數: 0, 領域排名: -%) Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review. Chao-Chin Hsu,Jui-Feng Hsu,Kuan-Li Wu - - 0 - Respirology case reports - 2021;9(6):e00753 (IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%) |
| 27 |
Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma. 顏孟畿,吳寬澧,劉又瑋,張永裕,張昭元,洪仁宇,蔡英明*,許雅玲 - - 1 - Biology(Basel) - BIOLOGY-BASEL 2021 10卷(5期):378頁 (IF: 5.079, 領域排名: 16, 領域期刊數: 93, 領域排名: 17.20%) Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma Meng-Chi Yen,Kuan-Li Wu,Yu-Wei Liu,Yung-Yun Chang,Chao-Yuan Chang,Jen-Yu Hung,Ying-Ming Tsai,Ya-Ling Hsu - - 1 - Biology(Basel) - BIOLOGY-BASEL 2021;10(5):378 (IF: 5.079, Journal Ranking: 16, Number of Journals of this Field: 93, Ranking: 17.20%) |
| 28 |
The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis 張昭元, 吳寬澧, 張永裕, 劉又瑋, 黃永琪, 簡淑芳, 林依宣, 蔡珮熏, 洪仁宇, 蔡英明*, 許雅玲 - - 1 - Journal of Personalized Medicine - JOURNAL OF PERSONALIZED MEDICINE 2021 11卷(6期):578頁 (IF: 4.945, 領域排名: 15, 領域期刊數: 108, 領域排名: 13.89%) The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis Chao-Yuan Chang, Kuan-Li Wu , Yung-Yun Chang , Yu-Wei Liu, Yung-Chi Huang, Shu-Fang Jian, Yi-Shiuan Lin, Pei-Hsun Tsai, Jen-Yu Hung, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - Journal of Personalized Medicine - JOURNAL OF PERSONALIZED MEDICINE 2021;11(6):578 (IF: 4.945, Journal Ranking: 15, Number of Journals of this Field: 108, Ranking: 13.89%) |
| 29 |
Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4 T‑cell recruitment to prolong survival in lung cancer. 張昭元, 吳寬澧, 張永裕, 蔡珮薰, 洪仁宇, 張維安, 簡淑芳, 黃永琪, 鍾飲文, 蔡英明*, 許雅玲 - - 1 - ONCOLOGY REPORTS - ONCOLOGY REPORTS 2021 46卷(3期):203頁 (IF: 3.906, 領域排名: 133, 領域期刊數: 242, 領域排名: 54.96%) Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4 T‑cell recruitment to prolong survival in lung cancer. Chao-Yuan Chang, Kuan-Li Wu, Yung-Yun Chang, Pei-Hsun Tsai, Jen-Yu Hung, Wei-An Chang, Shu-Fang Jian, Yung-Chi Huang, Inn-Wen Chong, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - ONCOLOGY REPORTS - ONCOLOGY REPORTS 2021;46(3):203 (IF: 3.906, Journal Ranking: 133, Number of Journals of this Field: 242, Ranking: 54.96%) |
| 30 |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study. Yen-Hsiang Huang#, 洪仁宇#, How-Wen Ko#, Po-Lan Su#, Chun-Liang Lai, Huang-Chih Chang, Te-Chun Hsia, Sheng-Hao Lin, 吳寬澧, Cheng-Ta Yang, 蘇五洲, Yi-Chun Chu, 王金洲, 廖唯昱, Yen-Ting Lin, Ching-Hsiung Lin, Meng-Chih Lin, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Mei-Hsuan Lee, Sung-Liang Yu, Chao-Chi Ho, Gee-Chen Chang - - 1 - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2021 13卷(0期):17588359211018022頁 (IF: 8.168, 領域排名: 15, 領域期刊數: 242, 領域排名: 6.20%) The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study. Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, Po-Lan Su, Chun-Liang Lai, Huang-Chih Chang, Te-Chun Hsia, Sheng-Hao Lin, Kuan-Li Wu, Cheng-Ta Yang, Wu-Chou Su, Yi-Chun Chu, Chin-Chou Wang, Wei-Yu Liao, Yen-Ting Lin, Ching-Hsiung Lin, Meng-Chih Lin, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Mei-Hsuan Lee, Sung-Liang Yu, Chao-Chi Ho, Gee-Chen Chang - - 1 - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2021;13(0):17588359211018022 (IF: 8.168, Journal Ranking: 15, Number of Journals of this Field: 242, Ranking: 6.20%) |
| 31 |
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis 吳寬澧,陳筱伶#,蔡英明,李岱晃,張秀美,蔡毓真,莊政皓,張詠婕,杜裕康,楊志仁*,洪仁宇,鍾飲文* - - 2 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2021 10卷(19期):4376頁 (IF: 4.241, 領域排名: 39, 領域期刊數: 169, 領域排名: 23.08%) First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis Kuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, Tai-Huang Lee, Hsiu-Mei Chang, Yu-Chen Tsai, Cheng-Hao Chuang, Yong-Chieh Chang, Yu-Kang Tu, Chih-Jen Yang, Jen-Yu Hung, Inn-Wen Chong - - 2 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2021;10(19):4376 (IF: 4.241, Journal Ranking: 39, Number of Journals of this Field: 169, Ranking: 23.08%) |
| 32 |
miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells. 張維安, 蔡明儒, 洪仁宇, 吳寬澧, 蔡英明, 黃永琪, 張昭元, 蔡珮熏, 許雅玲* - - 1 - CANCERS - CANCERS 2021 13卷(24期):6252頁 (IF: 6.639, 領域排名: 51, 領域期刊數: 242, 領域排名: 21.07%) miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells. Wei-An Chang, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Ya-Ling Hsu* - - 1 - CANCERS - CANCERS 2021;13(24):6252 (IF: 6.639, Journal Ranking: 51, Number of Journals of this Field: 242, Ranking: 21.07%) |
| 33 |
Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment Notch2-Jagged1 Interaction in Lung Cancer. 蔡英明,吳寬澧, 劉又瑋, 黃詠麒,張昭元, 蔡佩熏,Szi-Hui Liao, 洪仁宇, 許雅玲* - - 1 - FRONTIERS IN ONCOLOGY - FRONTIERS IN ONCOLOGY 2021 11卷(0期):696931頁 (IF: 6.244, 領域排名: 62, 領域期刊數: 242, 領域排名: 25.62%) Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment Notch2-Jagged1 Interaction in Lung Cancer. Ying-Ming Tsai, Kuan-Li Wu, Yu-Wei Liu, Wei-An Chang, Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Szi-Hui Liao, Jen-Yu Hung, Ya-Ling Hsu - - 1 - FRONTIERS IN ONCOLOGY - FRONTIERS IN ONCOLOGY 2021;11(0):696931 (IF: 6.244, Journal Ranking: 62, Number of Journals of this Field: 242, Ranking: 25.62%) |
| 34 |
半胱氨酸白三烯途徑與癌症 蔡明儒,張維安,莊政皓,吳寬澧,鄭至宏,許超群,洪仁宇* - - 1 - Int J Mol Sci - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021 23卷(1期):120頁 (IF: 5.924, 領域排名: 67, 領域期刊數: 295, 領域排名: 22.71%) Cysteinyl Leukotriene Pathway and Cancer Ming-Ju Tsai, Wei-An Chang, Cheng-Hao Chuang, Kuan-Li Wu, Chih-Hung Cheng, Chau-Chyun Sheu, Ya-Ling Hsu, Jen-Yu Hung - - 1 - Int J Mol Sci - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021;23(1):120 (IF: 5.924, Journal Ranking: 67, Number of Journals of this Field: 295, Ranking: 22.71%) |
| 35 |
Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer. 蔡英明,吳寬澧,張永裕,洪仁宇,張維安,張昭元,簡淑芳,蔡珮薰,黃永琪,鍾飲文,許雅玲* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 21卷(5期):E1640頁 (IF: 4.556, 領域排名: 74, 領域期刊數: 297, 領域排名: 24.92%) Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer. Ying-Ming Tsai , Kuan-Li Wu , Yung-Yun Chang , Jen-Yu Hung , Wei-An Chang , Chao-Yuan Chang , Shu-Fang Jian , Pei-Hsun Tsai , Yung-Chi Huang , Inn-Wen Chong , Ya-Ling Hsu* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020;21(5):E1640 (IF: 4.556, Journal Ranking: 74, Number of Journals of this Field: 297, Ranking: 24.92%) |
| 36 |
Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis 蔡英明,吳寬澧,張永裕,張維安,黃永琪,簡淑芳,蔡珮薰,林依宣,鍾飲文,洪仁宇*,許雅玲 - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 21卷(14期):5081頁 (IF: 4.556, 領域排名: 74, 領域期刊數: 297, 領域排名: 24.92%) Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2 alpha Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis Ying-Ming Tsai,Kuan-Li Wu ,Yung-Yun Chang ,Wei-An Chang ,Yung-Chi Huang ,Shu-Fang Jian ,Pei-Hsun Tsai ,Yi-Shiuan Lin ,Inn-Wen Chong ,Jen-Yu Hung ,* Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020;21(14):5081 (IF: 4.556, Journal Ranking: 74, Number of Journals of this Field: 297, Ranking: 24.92%) |
| 37 |
Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma. 陳筱伶,杜裕康,張秀美,李岱晃,吳寬澧,蔡毓真,李玫萱*,楊志仁*,洪仁宇,鐘飲文 - - 1 - Cancers - CANCERS 2020 12卷(12期):3629頁 (IF: 6.126, 領域排名: 37, 領域期刊數: 244, 領域排名: 15.16%) Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma. Hsiao-Ling Chen,Yu-Kang Tu,Hsiu-Mei Chang,Tai-Huang Lee,Kuan-Li Wu,Yu-Chen Tsai,Mei-Hsuan Lee,Chih-Jen Yang,Jen-Yu Hung,Inn-Wen Chong - - 1 - Cancers - CANCERS 2020;12(12):3629 (IF: 6.126, Journal Ranking: 37, Number of Journals of this Field: 244, Ranking: 15.16%) |
| 38 |
利用CHADS2及CHA2DS2ASc和ABCD分數以預測睡眠呼吸中止症病人周邊動脈疾病的發生 吳寬澧,郭家佑,蔡毓真,洪仁宇,許超群,楊志仁,徐崇堯,吳孟霓,蔡明儒* - - 1 - Journal of Clinical Medicine - JOURNAL OF CLINICAL MEDICINE 2019 8卷(2期):8(2). pii: E188頁 (IF: 5.688, 領域排名: 15, 領域期刊數: 160, 領域排名: 9.38%) CHADS2, CHA2DS2ASc, and New ABCD Scores Predict the Risk of Peripheral Arterial Disease in Patients with Sleep Apnea Wu K-L, Kuo C-Y, Tsai Y-C, Hung J-Y, Sheu C-C, Yang C-J, Hsu C-Y, Wu M-N, Tsai M-J - - 1 - Journal of Clinical Medicine - JOURNAL OF CLINICAL MEDICINE 2019;8(2):8(2). pii: E188 (IF: 5.688, Journal Ranking: 15, Number of Journals of this Field: 160, Ranking: 9.38%) |
| 39 |
The Roles of MicroRNA in Lung Cancer 吳寬澧,蔡英明, 連啟惇,郭柏麟,洪仁宇* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019 20卷(7期):1611頁 (IF: 4.183, 領域排名: 46, 領域期刊數: 172, 領域排名: 26.74%) The Roles of MicroRNA in Lung Cancer Kuan-Li Wu, Ying-Ming Tsai , Chi-Tun Lien, Po-Lin Kuo,Jen-Yu Hung - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019;20(7):1611 (IF: 4.183, Journal Ranking: 46, Number of Journals of this Field: 172, Ranking: 26.74%) |